The FDA approved a label update for Winrevair to include that it lowers the risk for clinical worsening events in adults with advanced pulmonary arterial hypertension. Mohammed Chowdhury, MD, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University, offered commentary to Healio on the clinical implications of the updated approval.
IMPORTANT: Labor & Delivery services have moved from Temple University Hospital–Main Campus (Broad & Ontario) to our new women & families hospital.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH